Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.

MLA

Spellmann, Ilja, et al. “Associations of NEUROD2 Polymorphisms and Change of Cognitive Dysfunctions in Schizophrenia and Schizoaffective Disorder after Eight Weeks of Antipsychotic Treatment.” Cognitive Neuropsychiatry, vol. 22, no. 4, July 2017, pp. 280–97. EBSCOhost, https://doi.org/10.1080/13546805.2017.1322502.

APA

Spellmann, I., Riedel, M., Städtler, J., Zill, P., Obermeier, M., Cerovecki, A., Dehning, S., Schennach, R., Epple, M., Opgen-Rhein, M., Müller, N., Bondy, B., Möller, H.-J., & Musil, R. (2017). Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment. Cognitive Neuropsychiatry, 22(4), 280–297. https://doi.org/10.1080/13546805.2017.1322502

Chicago

Spellmann, Ilja, Michael Riedel, Julia Städtler, Peter Zill, Michael Obermeier, Anja Cerovecki, Sandra Dehning, et al. 2017. “Associations of NEUROD2 Polymorphisms and Change of Cognitive Dysfunctions in Schizophrenia and Schizoaffective Disorder after Eight Weeks of Antipsychotic Treatment.” Cognitive Neuropsychiatry 22 (4): 280–97. doi:10.1080/13546805.2017.1322502.